Loading
Sarasota-based health care startup Omeza Holdings Inc. has named a new CEO and president, who will replace the company founder in that role.
Cynthia Flowers, the former CEO of Ipsen North America, stepped into the role May 1. While at Ipsen, a global biopharmaceutical company, Flowers oversaw the company’s transformation into the highest-growth Ipsen subsidiary in the world, according to a press release.
Omeza, a company in skin regenerative medicine, is known for its collagen matrix, an amorphous solid that acts as a skin substitute for chronic wounds.
"I believe that Omeza has a tremendous opportunity to make a meaningful impact in the healthcare industry,” Flowers says in the release, “and I am excited to be a part of this journey."
She succeeds the company’s founder Thomas Gardner, who was the previous CEO. Gardner will stay on as senior advisor to the board of directors through the end of 2024. In addition to her new position, Flowers will also join the board.
“Omeza Holdings' Board of Directors is thrilled to welcome Cynthia Flowers to the company,” chairman Dr. Joel Morganroth says, “and is confident that her leadership will drive growth and success for the organization.”
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
